People suffering from severe asthma were offered new hope after a jab was approved for use on the NHS. The National Institute for Health and Clinical Excellence (Nice) gave the go-ahead to omalizumab (Xolair) to treat severe persistent allergic asthma. The jab has been hailed as a breakthrough in stopping the body reacting severely to pollen, skin particles produced by cats and house-dust mite droppings.
Link to Article
Additional Stories
Jab gives hope to asthma sufferers - The Guardian 29th November 2007
Thursday, November 29, 2007
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment